A study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered with a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants

Trial Identifier: 214099
Sponsor: GlaxoSmithKline
Collaborator:
PPD Development LP
Start Date: December 2022
Primary Completion Date: October 2023
Study Completion Date: October 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, FL Orlando, FL, United States, 32806
United States, NV Las Vegas, NV, United States, 89113
United States, TX Austin, TX, United States, 78744